Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Smoking cessation and neuropsychiatric adverse events: are family physicians caught between a rock and a hard place?

Literature DB >> 21673204

Smoking cessation and neuropsychiatric adverse events: are family physicians caught between a rock and a hard place?

Charl Els¹, Diane Kunyk, Harkirat Sidhu.

Abstract

Mesh：

Substances：
Nicotinic Agonists

Year: 2011 PMID： 21673204 PMCID： PMC3114659

Source DB: PubMed Journal: Can Fam Physician ISSN： 0008-350X Impact factor: 3.275

× No keyword cloud information.

11 in total

1. The need for perspective in evidence-based medicine.

Authors: S H Woolf
Journal: JAMA Date: 1999 Dec 22-29 Impact factor: 56.272

2. A survey of tobacco dependence treatment guidelines in 31 countries.

Authors: Martin Raw; Susan Regan; Nancy A Rigotti; Ann McNeill
Journal: Addiction Date: 2009-07 Impact factor: 6.526

3. The impact of caffeine use on tobacco cessation and withdrawal.

Authors: J A Swanson; J W Lee; J W Hopp; L S Berk
Journal: Addict Behav Date: 1997 Jan-Feb Impact factor: 3.913

4. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.

Authors: Tomas Herraiz; Carolina Chaparro
Journal: Biochem Biophys Res Commun Date: 2005-01-14 Impact factor: 3.575

5. Smoking and mental illness: A population-based prevalence study.

Authors: K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal: JAMA Date: 2000 Nov 22-29 Impact factor: 56.272

Review 6. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

Authors: Hans Rollema; Jotham W Coe; Leslie K Chambers; Raymond S Hurst; Stephen M Stahl; Kathryn E Williams
Journal: Trends Pharmacol Sci Date: 2007-06-18 Impact factor: 14.819

Smoking cessation and neuropsychiatric adverse events: are family physicians caught between a rock and a hard place?

1. The need for perspective in evidence-based medicine.

2. A survey of tobacco dependence treatment guidelines in 31 countries.

3. The impact of caffeine use on tobacco cessation and withdrawal.

4. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.

5. Smoking and mental illness: A population-based prevalence study.

Review 6. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

Review 7. Update on pharmacologic and nonpharmacologic therapies for smoking cessation.

8. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.

Review 9. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities.

Review 10. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.

1. Tobacco use disorder treatment in primary care: implementing a clinical system pathway in Alberta.